GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a substantial development in how we approach type 2 diabetes . These new drugs function to stimulating the body’s inherent https://socialicus.com/story7252523/glp-1-a-major-breakthrough-in-diabetes-treatment